...
首页> 外文期刊>International Journal of Pharmaceutical Sciences Review and Research >Improving Solubility and Bioavailability of Poorly Water Soluble Drugs by Solid Dispersion Technique – A Review”
【24h】

Improving Solubility and Bioavailability of Poorly Water Soluble Drugs by Solid Dispersion Technique – A Review”

机译:通过固体分散技术提高水溶性差的药物的溶解度和生物利用度–综述”

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The objective of this study was to develop sustained release mucoadhesive tablets of lovastatin by using hydrophilic polymers like chitosan, xanthan gum, karaya gum and HPMC K15M. Lovastatin is an anti-hyperlipidimic agent which has low bioavailability due to extensive first pass metabolism. It was sought to increase gastric retention time of lovastatin by development of sustained release mucoadhesive tablets leading to reduce fluctuation in the plasma concentration and improved bioavailability. Lovastatin tablets were prepared by wet granulation method the drug polymer mixtures were subjected to preformulation studies. FTIR studies showed that there was no interaction between drug and polymer. The granules were evaluated for angle of repose, bulk density, Carr’s index, Hausner’s ratio and the tablets were subjected to thickness, weight variation, drug content, hardness, friability, surface pH, swelling index, mucoadhesive strength and In-vitro studies. The results were found to be within the limits. The drug release studies were carried out for 12hours. In which formulation with combination of chitosan and karaya gum with the ratio of (1:1.5:1.5) was selected as an optimized formulation which have drug release of 98.89% in 12hours. Mathematical analysis of the release kinetics indicates that nature of drug release from the mucoadhesive tablets follows non-fickian diffusion mechanism. Formulation F9 was selected as optimized batch from all the formulations due to their improved bioavailability.
机译:这项研究的目的是通过使用壳聚糖,黄原胶,卡拉叶胶和HPMC K15M等亲水性聚合物开发洛伐他汀的缓释粘膜粘附片剂。洛伐他汀是一种抗高血脂药,由于广泛的首过代谢,所以生物利用度低。寻求通过开发持续释放的粘膜粘附片剂来增加洛伐他汀在胃中的停留时间,从而降低血浆浓度的波动并提高生物利用度。洛伐他汀片通过湿法制粒法制备,药物聚合物混合物经过预制剂研究。 FTIR研究表明,药物与聚合物之间没有相互作用。评价颗粒的休止角,堆积密度,卡尔指数,豪斯纳比,并对片剂进行厚度,重量变化,药物含量,硬度,脆性,表面pH,溶胀指数,粘膜粘附强度和体外研究。发现结果在极限范围内。药物释放研究进行了12小时。其中以(1:1.5:1.5)的比例结合壳聚糖和卡拉胶的配方被选为优化配方,其在12小时内的药物释放率为98.89%。释放动力学的数学分析表明,从粘膜粘附片剂释放的药物的性质遵循非菲尼克斯扩散机制。由于其改善的生物利用度,因此从所有配方中选择配方F9作为优化批次。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号